"The NHS' puberty blockers trial is "designed to reach a negative conclusion", according to a leading UK trans rights organisation."
"The trial's methodology is inherently coercive and inappropriate in what it is measuring - as though it is designed to reach a negative conclusion."
"Gender related healthcare for young people has become a mess, treating patients with suspicion and delaying and banning treatments based on treating being trans as a risk rather than natural human variation."
"" holistic approach ""
A £10 million NHS-commissioned PATHWAYS trial led by King's College London will analyse physical and social wellbeing of trans young teenagers taking puberty suppressants. The study was commissioned after the government indefinitely extended a ban on the treatment following the Cass Review and calls for a " holistic approach ". Critics, including TransActual healthcare director Chay Brown, say the trial requires under-18s to undergo hours of medical assessments that are invasive, coercive, and likely to produce a negative finding. Several major health organisations have expressed concern amid international research describing puberty blockers as safe, effective, and potentially life-saving.
Read at PinkNews | Latest lesbian, gay, bi and trans news | LGBTQ+ news
Unable to calculate read time
Collection
[
|
...
]